Dhaval Champaklal Vankani
About Dhaval Champaklal Vankani
Data last updated:
Dhaval Champaklal Vankani has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Aura Drugs And Intermediates Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aura Drugs And Intermediates Private Limited at ₹0.00 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aura Drugs And Intermediates Private Limited U24299GJ2021PTC121215 | Director | 16 Mar 2021 | 2021 | ₹0.00 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhaval Champaklal Vankani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhaval Champaklal Vankani
Dhaval Champaklal Vankani has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Aura Drugs And Intermediates Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aura Drugs And Intermediates Private Limited at ₹0.00 Cr (FY 2023).
Dhaval Champaklal Vankani is associated with 1 company as Director, including Aura Drugs And Intermediates Private Limited (₹0.00 Cr).
Dhaval Champaklal Vankani has expertise in General Business.
Dhaval Champaklal Vankani has 5 years in corporate governance.
By reported revenue, the largest current company of Dhaval Champaklal Vankani is Aura Drugs And Intermediates Private Limited, with revenue of ₹0.00 Cr (FY 2023).
Dhaval Champaklal Vankani currently holds positions at 1 company: Aura Drugs And Intermediates Private Limited (₹0.00 Cr).